... San Antonio Breast Cancer Symposium (SABCS). Vepdegestrant is a novel ... Arvinas is a clinical-stage biotechnology company dedicated to improving ...
News
- Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at ...
- Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented ... - Benzinga
today announced that updated clinical trial data for vepdegestrant (ARV-471) will be presented at the 2023 San Antonio Breast Cancer Symposium (SABCS) ...
- Hayward cancer biotech eyes $200 million in fresh capital - The Business Journals
San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay · Washington, D.C. · Wichita. Close Menu. BAYAREAINNO. EVERY INNO STORY.
- Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at ...
(NYSE: PFE) today announced that updated clinical trial data for vepdegestrant (ARV-471) will be presented at the 2023 San Antonio Breast Cancer ...
- bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, ...